Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Biotech
Novo taps Photys for multi-molecule cardiometabolic collab
Novo Nordisk will pay Photys up to $186 million to help develop proximity-based therapeutics for an unnamed cardiometabolic disease target.
Fraiser Kansteiner
Dec 18, 2024 7:30am
Evotec, Novo collab debuts first 3 projects, adds 5 partners
Dec 12, 2024 2:27pm
Novo Nordisk discards $1.3B kidney drug in wake of phase 3 fail
Nov 6, 2024 4:54am
In $285M deal, Novo taps Ascendis to help create monthly GLP-1
Nov 4, 2024 8:43am
Novo obesity prospect linked to ‘neuropsychiatric side effects’
Sep 20, 2024 10:25am
Novo inks $600M NanoVation deal to study genetic drugs ex-liver
Sep 18, 2024 9:03am
